Browse studies, page 1314
Page 1314 of 1,318, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis The Journal of infectious diseases, 2025
- Belantamab mafodotin, lenalidomide, and dexamethasone for intermediate-fit and frail patients with newly diagnosed myeloma Blood, 2026
- Infections in patients receiving daratumumab for newly diagnosed multiple myeloma: a pooled analysis of MAIA and ALCYONE Blood advances, 2026
- Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2024
- Study protocol for a multicenter, multinational prospective randomized controlled trial comparing outcomes in subjects with Gram-negative bacteremia who have blood culture evaluation using Fast Antibiotic Susceptibility Testing vs. standard of care testing: the FAST trial Trials, 2025
- Comparison of remimazolam versus propofol under deep sedation for elderly patients during prostate biopsy: a protocol for a randomised controlled trial BMJ open, 2026
- Prime Editing for p47phox-Deficient Chronic Granulomatous Disease The New England journal of medicine, 2026
- Venetoclax in combination with cytarabine with or without idarubicin or azacitidine in children, adolescents, and young adults with relapsed or refractory acute myeloid leukaemia (VENAML): a multicentre, phase 1 expansion study The Lancet. Haematology, 2026
- Impact of drug-resistance diagnosis based on whole-genome sequencing on the treatment adequacy of patients with drug-resistant pulmonary tuberculosis in the state of São Paulo, Brazil: a protocol for a non-randomised controlled trial (Gen-TB PróCura) BMJ open, 2025
- Application of directional customized corneal relaxing incision in EVO ICL implantation: high myopia with low astigmatism BMC ophthalmology, 2026
- Efficacy of 1.5% levofloxacin otic solution in treating acute otitis externa: A post hoc analysis of ENT103-3001, a multicenter randomized double-blind parallel-group placebo-controlled phase III study in otitis media with persistent otorrhea Auris, nasus, larynx, 2024
- Efficacy of susceptibility-guided quadruple therapy with antibiotic resistance using the string test coupled with quantitative PCR for Helicobacter pylori eradication: a protocol of a multicentre, open, randomised clinical trial BMJ open, 2024
- Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Blood advances, 2026
- Study protocol for a duration-randomized clinical trial to determine the optimal length of treatment for multidrug-resistant tuberculosis with a 5-drug regimen: The DRAMATIC trial Contemporary clinical trials, 2025
- Effectiveness and safety of shortened intensive treatment for children with tuberculous meningitis (SURE): a protocol for a phase 3 randomised controlled trial evaluating 6 months of antituberculosis therapy and 8 weeks of aspirin in Asian and African children with tuberculous meningitis BMJ open, 2025
- Pharmacokinetics, bactericidal activity and toxicity of short oral regimens for rifampicin-resistant tuberculosis treatment Nature communications, 2026
- Safety of liposomal daunorubicin-cytarabine (CPX-351) in secondary AML: Japanese phase 1/2 study and global phase 3 study International journal of hematology, 2025
- A non-randomized pragmatic historically controlled trial evaluating the effectiveness and safety of a bedaquiline or a linezolid-based short regimen for rifampicin-resistant tuberculosis The Journal of infection, 2024
- A Prospective Cohort Study on the Usage, Safety, and Efficacy of Delamanid in Patients With Pulmonary Multidrug-Resistant Tuberculosis in South Korea Open forum infectious diseases, 2025
- Evaluation of an oral bedaquiline regimen for treating multidrug-resistant TB in China: a randomized trial Infection, 2026
- Vonoprazan-Amoxicillin Dual Therapy with or Without Saccharomyces boulardii Supplementation as a Rescue Regimen for Helicobacter pylori Infection Infection and drug resistance, 2026
- Lascufloxacin switch therapy versus ampicillin/sulbactam for older patients with community-acquired pneumonia in Japan (STEP study): a study protocol for a multicentre open-label randomised controlled non-inferiority trial BMJ open, 2026
- Effectiveness of Doxycycline in Combination With Other Antibiotics for Gram-Positive Periprosthetic Joint Infections: A Causal Inference Study Open forum infectious diseases, 2026
- Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis Open forum infectious diseases, 2025
- Protecting households on exposure to newly diagnosed index multidrug-resistant tuberculosis patients: Study protocol for the PHOENIx phase 3 clinical trial Contemporary clinical trials, 2025
- The Use of Step-Down Oral Antibiotic Therapy for Uncomplicated Gram-Negative Bacteremia and Risk Factors for Adverse Outcomes Open forum infectious diseases, 2026
- Hypoalbuminemia and reduced sputum microbiome diversity associated with antibiotic treatment failure in nursing and healthcare-associated pneumonia Drug discoveries & therapeutics, 2026
- Direct stimulation of acupuncture at extraocular muscle attachment point for 13 cases of acquired extraocular muscle palsy Zhongguo zhen jiu = Chinese acupuncture & moxibustion, 2025
- Bismuth-Based quintuple therapy: a step beyond quadruple regimens in H. Pylori treatment and the impact of patient compliance BMC gastroenterology, 2025
- Population-based study of pharmacogenetics and pharmacokinetics in Southern African patients with multidrug-resistant tuberculosis (PoPG): a protocol for the Namibian cohort BMJ open, 2026
- Administration of levofloxacin combined with metronidazole suppositories prior to in vitro fertilisation in women with chronic endometritis: a protocol of a single-centre, randomised, controlled clinical trial BMJ open, 2025
- Cefadroxil as Oral Transitional Therapy for Gram-Positive Bacteremia With or Without Non-Vertebral Osteomyelitis: A Multicenter Retrospective Cohort Study Open forum infectious diseases, 2026
- Pharmacokinetics and safety of MP-376 (levofloxacin inhalation solution) in cystic fibrosis subjects Antimicrobial agents and chemotherapy, 2011
- Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia Bangladesh Medical Research Council bulletin, 2009
- The effects of levofloxacin on ECG parameters and late potentials American journal of therapeutics, 2005
- Assessment of musculoskeletal toxicity 5 years after therapy with levofloxacin Pediatrics, 2014
- Phase II clinical trial for prevention of delayed diarrhea with cholestyramine/levofloxacin in the second-line treatment with irinotecan biweekly in patients with metastatic colorectal carcinoma Oncology, 2007
- Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication Alimentary pharmacology & therapeutics, 2010
- Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate Southern medical journal, 2007
- Comparing the Efficacy of Sequential and Standard Quadruple Therapy for Eradication of H. Pylori Infection Acta medica (Hradec Kralove), 2020
- The clinical and bacteriological factors for optimal levofloxacin-containing triple therapy in second-line Helicobacter pylori eradication PloS one, 2014
- Pharmacokinetics of multiple intravenous instillation of levofloxacin in Chinese healthy subjects Acta pharmacologica Sinica, 2002
- Intrapulmonary concentration of levofloxacin in patients with idiopathic pulmonary fibrosis Pulmonary pharmacology & therapeutics, 2014
- Aqueous and vitreous penetration of linezolid and levofloxacin after oral administration Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2010
- Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications Medecine et maladies infectieuses, 2005
- Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial Gut, 2010
- Comparison of 10-day levofloxacin bismuth-based quadruple therapy and levofloxacin-based triple therapy for Helicobacter pylori Journal of digestive diseases, 2017
- Antibiotic prophylaxis in transarterial chemoembolization of hepatocellular carcinoma Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2018
- Levofloxacin-amoxicillin/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection BioMed research international, 2014
- Levofloxacin pharmacokinetics in children Journal of clinical pharmacology, 2005
- Evaluation of analgesic activity of levofloxacin in human experimental pain model Journal of basic and clinical physiology and pharmacology, 2015
- Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration European journal of ophthalmology, 2007
- Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man Drug metabolism and drug interactions, 1996
- Assessment of Helicobacter pylori eradication rate of triple combination therapy containing levofloxacin The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2011
- Pharmacokinetics and optimized dosing of dispersible and non-dispersible levofloxacin formulations in young children The Journal of antimicrobial chemotherapy, 2023
- Safety and effectiveness of vonoprazan-based rescue therapy for Helicobacter pylori infection World journal of gastroenterology, 2023
- Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia International journal of hematology, 2017
- A study on the efficacy and safety of fecal microbiota transplantation as an adjunctive therapy for treating depressive episodes Scientific reports, 2026
- Comparison of Cefuroxime-Based Dual Therapy With Quadruple Therapy in Helicobacter pylori-Infected Treatment-Naive Patients: A Prospective, Multicenter, Randomized Controlled Trial Helicobacter, 2025
- Enteral versus intravenous antibiotics for critically ill patients: A pilot study The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2025
- Effects of Huang'e Capsules on type IIIA prostatitis and inflammatory cytokines in the expressed prostatic secretion of the patient Zhonghua nan ke xue = National journal of andrology, 2024
- Comparison of the prophylactic effect of cefazolin injection versus oral levofloxacin as prophylactic antibiotic in TURP surgery: a randomized clinical trial BMC pharmacology & toxicology, 2024
- Effect of HIV on bedaquiline and delamanid pharmacokinetics in patients with multidrug-resistant TB The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2025
- Comparison of the effectiveness of single-dose levofloxacin with single-dose fosfomycin pre-urodynamic study related to the incidence of urinary tract infection: a randomized controlled trial BMC urology, 2025
- 14-day Empirical Therapy Compared with 7-day Tailored Therapy for Helicobacter pylori Eradication in Korea: Results of the K-CREATE Phase II Study Yonsei medical journal, 2026
- Clinical observation of early postoperative wear of balafilcon A and innovative first-generation samfilcon a silicone hydrogel bandage contact lenses after SMILE surgery BMC research notes, 2025
- Randomized controlled diagnostic trial to assess dRAST time to result and its utility for antimicrobial stewardship recommendation in bacteremic patients Microbiology spectrum, 2025
- Comparison of preoperative 5% povidone-iodine plus moxifloxacin versus 5% povidone-iodine alone on ocular surface bacterial flora: protocol for a randomized controlled trial BMC ophthalmology, 2026
- Rebamipide for Managing Dyspeptic Symptoms During Proton-Pump Inhibitor Washout Before Helicobacter pylori Testing: A Randomized, Double-Blind, Placebo-Controlled Trial The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2025
- Four-Week vs Six-Week Antibiotic Therapy in the Management of Nonsurgically Treated Diabetic Foot Osteomyelitis: Protocol for a Multicentric, Single-Blind Randomized Clinical Trial JMIR research protocols, 2026
- The effect of psychological intervention combined with standard pharmacological therapy in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): A randomized controlled trial Medicine, 2025
- Eradication of Helicobacter pylori that contributes to hepatogenic ulcer is beneficial to the healing of hepatogenic ulcer BMC gastroenterology, 2025
- The effect of povidone-iodine 10% plus levofloxacin 0.5% before cataract surgery: a randomized clinical trial BMC research notes, 2025
- Innovating shorter, all-oral, precise, individualized treatment regimen for rifampicin-resistant tuberculosis (INSPIRE TB): study protocol for a pragmatic randomised controlled trial BMC infectious diseases, 2026
- Vonoprazan-amoxicillin dual therapy combined with probiotics for Helicobacter pylori eradication: a prospective, multicenter, randomized controlled trial BMC gastroenterology, 2026
- The efficacy of combined bandage contact lens and nasal margin suture fixation in pterygium patients and its impact on inflammatory cytokines Scientific reports, 2026
- Cost-Effectiveness of Oral Levofloxacin Versus Amoxicillin-Clavulanate/Ciprofloxacin for Outpatient Management of Low-Risk Febrile Neutropenia in Children With Cancer in Egypt JCO global oncology, 2025
- A 6- to 9-months oral regimen for rifampicin-resistant tuberculosis: a randomized open-label noninferiority trial in China Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2026
- Antimicrobial Photodynamic Therapy in the Treatment of Diabetic Foot Ulcers: A Pilot Randomized Clinical Trial Journal of biophotonics, 2026
- Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial) Scientific reports, 2025
- Clinical efficacy of abdominal moxibustion at the Zhongji (CV3) in combination with Yiqi Tonglin Yangyin decoction and antibiotics for treating elderly female patients with complicated urinary tract infection Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2026
- Vonoprazan-based dual therapy with amoxicillin or doxycycline versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a prospective, multicenter, open-label, randomized controlled trial Frontiers in cellular and infection microbiology, 2026
- Effect of a modified soft contact lens combined with a noncontact wide-angle viewing system during vitrectomy Medicine, 2026
- Comparison of the efficacy and safety of levofloxacin eye drops and pranoprofen gel in the treatment of bacterial conjunctivitis in the real world Pakistan journal of pharmaceutical sciences, 2025
- Analysis of the efficacy of fosfomycin trometamol in preventing biofilm bacterial infection in double-J stents among diabetic patients and the factors associated with infection International urology and nephrology, 2026
- 14-Day Vonoprazan-Minocycline Dual Therapy Versus Bismuth-Containing Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Single-Center Randomized Controlled Noninferiority Trial Helicobacter, 2026
- Efficacy and Safety of Levofloxacin- Versus Moxifloxacin-Based Nitazoxanide Quadruple Therapy as Second-Line Treatment for Helicobacter pylori in Egypt: A Randomized Multicenter Trial Helicobacter, 2026
- Levofloxacin versus moxifloxacin in nitazoxanide-based quadruple therapy as a first-line treatment for Helicobacter pylori infection: NILE, a randomized, comparative, multicenter study Scientific reports, 2026
- On Hierarchical Composite Endpoints in Pediatric Cancer Supportive Care: Illustrative Examples From Two Multi-Center Phase-III Randomized Clinical Trials Pediatric blood & cancer, 2026
- Efficacy and Safety of Yinhua Miyanling Tablets for Uncomplicated Urinary Tract Infections: A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Non-inferiority Clinical Trial Chinese journal of integrative medicine, 2026
- Susceptibility-Guided Versus Empirical Therapy for Helicobacter pylori Infection in a High Resistance Setting: A Randomised Controlled Trial MicrobiologyOpen, 2026
- Helicobacter pylori Eradication in the Era of Rising Antibiotic Resistance: A Randomized Controlled Comparison of Clarithromycin- and Levofloxacin-Based Triple Therapy with or without Lactoferrin La Clinica terapeutica, 2026
- Complex therapy of chronic bacterial prostatitis using the immunomodulatory drug sodium aminodihydrophthalazinedione Urologiia (Moscow, Russia : 1999), 2026
- Effectiveness of 1.25 % povidone-iodine combined with topical levofloxacin against conjunctival flora in intravitreal injection Japanese journal of ophthalmology, 2012
- A multi-center, randomized, controlled, double blind and double dummy clinical trial of antofloxacin hydrochloride tablet versus levofloxacin tablet for the treatment of acute bacterial infections Zhonghua nei ke za zhi, 2011
- Factors associated with screening failure and study withdrawal in multidrug-resistant TB. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2022
- Comparison of Topical Gatifloxacin and Levofloxacin at Different Durations in Eliminating Conjunctival Bacterial Flora Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2025
- Efficacy of 1-day prophylaxis medication with fluoroquinolone for prostate biopsy World journal of urology, 2005
- Tigecycline versus levofloxacin for the treatment of community-acquired pneumonia: European experience Journal of chemotherapy (Florence, Italy), 2008
- Effectiveness and tolerability of short course co-trimoxazole, norfloxacin and levofloxacin in bacteriological cure of uncomplicated urinary tract infection in outpatient setting. An open label, parallel group, randomized controlled trial Le infezioni in medicina, 2015
